First report of chromenyl derivatives from spineless marine cuttlefish Sepiella inermis: Prospective antihyperglycemic agents attenuate serine protease dipeptidyl peptidase‐IV

Krishnan, Soumya and Chakraborty, Kajal and Joy, Minju (2019) First report of chromenyl derivatives from spineless marine cuttlefish Sepiella inermis: Prospective antihyperglycemic agents attenuate serine protease dipeptidyl peptidase‐IV. Journal of Food Biochemistry, 43 (5). pp. 1-12.

[img] Text
Journal of Food Biochemistry_2019_Kajal Chakraborty_Prospective anti-hyperglycemic agents attenuate serine protease dipeptidyl peptidase-IV.pdf
Restricted to Registered users only

Download (833kB) | Request a copy | Please mail the copy request to cmfrilibrary@gmail.com
Official URL: https://onlinelibrary.wiley.com/doi/abs/10.1111/jf...
Related URLs:

    Abstract

    Spineless marine cuttlefish Sepiella inermis has been considered as a popular dietary cephalopod species in Asian and Mediterranean coasts. Bioassay‐directed purification of organic extract of S. inermis ensued in the characterization of two chromenyl derivatives. The studied compounds exhibited significantly greater antioxidant potencies (IC50 ≤ 0.5 mg/ml) when compared with α‐tocopherol. The substituted 1H‐ isochromenyloxy‐11‐hydroxyethyl pentanoate isoform (compound 1) efficiently inhibited the carbolytic enzymes along with key regulator of insulin secretion dipeptidyl peptidase‐IV (IC50 0.16 mg/ml). The molecular docking simulations displayed optimum binding affinity of the compound 1 (−10.01 kcal/mol) with dipeptidyl peptidase‐IV and lesser inhibition constant (Ki 46.41 nM), which along with its permissible hydrophobic‐hydrophilic balance (log Pow ~ 2) appeared to play significant roles in its greater antihyperglycemic activity compared to other studied chromenyl isoform. The greater antioxidant and antidiabetic properties of compound 1 could be utilized as an important natural lead against hyperglycemic‐related disorders.

    Item Type: Article
    Uncontrolled Keywords: antihyperglycemic, chromenyl derivatives, dipeptidyl peptidase‐IV, molecular docking simulations, Sepiella inermis
    Subjects: Fish Biotechnology > Bioactive compound
    Molluscan Fisheries > Cephalopods
    Fish Biotechnology
    Divisions: CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI > CMFRI-Kochi > Marine Biotechnology
    CMFRI-Kochi > Marine Biotechnology
    Subject Area > CMFRI-Kochi > Marine Biotechnology
    Depositing User: Arun Surendran
    Date Deposited: 10 May 2019 06:53
    Last Modified: 08 Apr 2022 08:35
    URI: http://eprints.cmfri.org.in/id/eprint/13641

    Actions (login required)

    View Item View Item